The need for standardization in exercise challenge testing for exercise-induced asthma/bronchoconstriction - 07/08/11
Doi : 10.1016/j.jaci.2010.07.032
Michael K. Stickland, PhD a 
, Carol H. Spooner, BScN, MSc b, Donna M. Dryden, PhD b, Brian H. Rowe, MD, MSc, CCFP (EM) c
, Carol H. Spooner, BScN, MSc b, Donna M. Dryden, PhD b, Brian H. Rowe, MD, MSc, CCFP (EM) c a Department of Medicine, University of Alberta & Centre for Lung Health (Covenant Health), Edmonton, Alberta, Canada
b University of Alberta Evidence-based Practice Center, Edmonton, Alberta, Canada
c Department of Emergency Medicine and School of Public Health, University of Alberta, Edmonton, Alberta, Canada
| Supported by the Canadian Institutes for Health Research (CIHR; Ottawa, Ontario, Canada) New Investigator Award (M. K. S.) and the Canada Research Chair (B. H. R.) from the Government of Canada (Ottawa, Ontario, Canada). |
|
| Disclosure of potential conflict of interest: M. K. Stickland has received speaking honoraria from GlaxoSmithKline. B. H. Rowe received funding for this report from EPC-AHRQ. The rest of the authors have declared that they have no conflict of interest. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 126 - N° 4
P. 878 - octobre 2010 Regresar al número
Artículo precedente
- IL-4 receptor ⍺ polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist
- Rebecca E. Slager, Gregory A. Hawkins, Elizabeth J. Ampleford, Alexandra Bowden, Lauren E. Stevens, Matthew T. Morton, Adrian Tomkinson, Sally E. Wenzel, Malinda Longphre, Eugene R. Bleecker, Deborah A. Meyers
- Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia
- Hak-Ryul Kim, Chang-Duk Jun, Young-Jin Lee, Sei-Hoon Yang, Eun-Taik Jeong, Seok-Don Park, Do-Sim Park
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?